Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Eric Pujade-Lauraine

A Phase 3 Trial of Bevacizumab in Ovarian Cancer ⬇️

scientific article published on December 29, 2011

Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future

scientific article published on 14 November 2015

Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer ⬇️

scientific article published on 04 July 2013

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial

scientific article

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial

scientific article

Clinical Trials in Recurrent Ovarian Cancer ⬇️

scientific article published on May 1, 2011

Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

scientific article published on February 2011

Economic assessment of Caelyx versus topotecan in advanced ovarian cancer

scientific article

Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset

scientific article published on 18 May 2012

HER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients

scientific article

Incorporation of pazopanib in maintenance therapy of ovarian cancer

scientific article

Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer

scientific article published on 13 May 2016

Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients

scientific article published on 30 June 2010

New clinical research strategies for rare gynecologic malignancies

scientific article published on February 2015

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

scientific article

Once-weekly treatment of anemia in patients with cancer: a comparative review of epoetins

scientific article

Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets ⬇️

scientific article published on November 25, 2011

Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells ⬇️

scientific article published on July 18, 2013

Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer ⬇️

scientific article published on August 1, 2010

Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: Results of a pooled analysis of three GINECO phase II trials

scientific article published on April 2016

Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer

scientific article published on February 2007

Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study

scientific article published on 26 January 2016

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial ⬇️

scientific article

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

scientific article published on 18 January 2013

Sustained response to vemurafenib in a low grade serous ovarian cancer with a BRAF V600E mutation

scientific article published on 21 October 2015

Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab ⬇️

scientific article published on 28 June 2016

Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study

scientific article

The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials

scientific article published on May 2017

The burden of anaemia in patients with cancer

scientific article published in January 2004

The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: data from CALYPSO trial (a GINECO-GCIG study).

scientific article

Paulina is supported by:

About Paulina

Help